Filing Flows › Fulgent Genetics (FLGT) › Stock forecast & fair value
Fulgent Genetics (FLGT) stock forecast and price target
Fulgent Genetics (FLGT) trades at $23.74. One analyst's price target is $19.00 (-20%).
Fulgent Genetics' latest quarter
Fulgent Genetics, Q3 2026: revenue $90.4M (+8% year over year), operating margin -24.9%, net loss $13.3M, operating cash flow $109M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for FLGT stock?
One analyst's 12-month target is $19.00, -20% from $23.74. The average rating is none.
Does Fulgent Genetics usually beat earnings estimates?
It beat the consensus EPS estimate in 60% of the quarters on record.
Is FLGT stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.